Additionally, the borderline significance of the signature in the patients with advanced stage disease, sampled from the independent cohort, might be attributable to the small size of this cohort.
← all excerpts
Comprehensive molecular analyses of a TNF family-based signature with regard to prognosis, immune features, and biomarkers for immunotherapy in lung adenocarcinoma.
1
—
—